Trial Profile
A study evaluating efficacy of bevacizumab combination therapy in advanced colorectal cancer patients.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 17 Apr 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 17 Apr 2017 Status changed from completed to recruiting.
- 17 Apr 2017 New trial record